Cummins Inc. (CMI) Falls 3.2% for February 10

Equities Staff |

One of the S&P 500’s big losers for Wednesday February 10 was Cummins Inc. (CMI). The company’s stock fell 3.2% to $96.51 on volume of 3.37 million shares.

The stock opened the day at 100.58 and traded between a low of $95.71 and a high of $100.79. The stock finished the day down $3.19 per share. Cummins Inc. has an average daily volume of 2.8 million and a total float of 177.62 million shares. The 50-day SMA for Cummins Inc. is $89.36 and its 200-day SMA is $113.40. The high for the stock over the last 52 weeks is $146.13 and the low is $79.88.

Cummins Inc designs, manufactures, distributes and services diesel and natural gas engines, electric power generation systems and engine-related component products.

Cummins Inc. is centered in Columbus, IN, and has 54,600 employees. Today’s trading day leaves the company with a market cap of $17.14 billion. The company has a P/S ratio of n/a, P/B ratio of 2.21, and a 42.5.

For a complete fundamental analysis analysis of Cummins Inc., check out Equities.com’s Stock Valuation Analysis report for CMI. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Snapwire

A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…